2009
DOI: 10.1128/aac.00484-09
|View full text |Cite
|
Sign up to set email alerts
|

Impact of sarA on Daptomycin Susceptibility of Staphylococcus aureus Biofilms In Vivo

Abstract: We used a murine model of catheter-associated biofilm formation to determine whether the mutation of the staphylococcal accessory regulator (sarA) has an impact on the susceptibility of established Staphylococcus aureus biofilms to treatment with daptomycin in vivo. The experiments were done with two clinical isolates, one of which (UAMS-1) was obtained from the bone of a patient suffering from osteomyelitis, while the other (UAMS-1625) is an isolate of the USA300 clonal lineage of community-acquired methicill… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

10
105
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
9
1

Relationship

4
6

Authors

Journals

citations
Cited by 67 publications
(115 citation statements)
references
References 43 publications
10
105
0
Order By: Relevance
“…Three of these genes encode well-studied mediators of S. aureus biofilm formation and ␤-lactam resistance: atl (discussed above), sarA, and mecA. Mutations in sarA decrease S. aureus biofilm and increase antibiotic susceptibility both in vitro and in vivo (31,57), whereas mutations in mecA, which encodes penicillin binding protein 2a, impede resistance to ␤-lactam antibiotics (58). Several other genes identified in our screen have also been associated with biofilm formation (codY), ␤-lactam resistance (fmtC and vraR), or both processes (rsbU, rsbW, fmtA, and rsh) (4,10,16,(33)(34)(35)(36)(37)(38)(39).…”
Section: Discussionmentioning
confidence: 99%
“…Three of these genes encode well-studied mediators of S. aureus biofilm formation and ␤-lactam resistance: atl (discussed above), sarA, and mecA. Mutations in sarA decrease S. aureus biofilm and increase antibiotic susceptibility both in vitro and in vivo (31,57), whereas mutations in mecA, which encodes penicillin binding protein 2a, impede resistance to ␤-lactam antibiotics (58). Several other genes identified in our screen have also been associated with biofilm formation (codY), ␤-lactam resistance (fmtC and vraR), or both processes (rsbU, rsbW, fmtA, and rsh) (4,10,16,(33)(34)(35)(36)(37)(38)(39).…”
Section: Discussionmentioning
confidence: 99%
“…Based on a specific interest in musculoskeletal infection, much of our research has been directed toward defining the mechanistic basis for S. aureus biofilm formation, and these studies have led us to conclude that the staphylococcal accessory regulator (sarA) plays a primary role in this regard. Specifically, we have demonstrated that mutation of sarA in diverse clinical isolates, including those of the USA300 lineage of community-associated methicillin-resistant S. aureus (CA-MRSA), limits biofilm formation to a degree that can be correlated with increased susceptibility to functionally distinct classes of antibiotics under both in vitro and in vivo conditions (1,2,45,47,48). This suggests that sarA would be a viable target for the development of therapeutic agents capable of overcoming the intrinsic resistance of biofilm-associated infections.…”
mentioning
confidence: 99%
“…The limitations of the animal model include the small size, soft tissue instead of orthopaedic implantation, and limited diffusion of physiologic substances within the sequestrum of the catheter. The animal model is useful as a screening tool for antibiofilm activity in vivo [54,74,75], where the catheter serves as a sequestrum for localizing the bacterial inoculum and as a nidus for biofilm formation. Because of difficulty in applying coatings directly to the catheter, we modified the catheter-associated biofilm model by including an easily coated stainless steel wire.…”
Section: Discussionmentioning
confidence: 99%